AVDL 7.68 (+7.71%)
US05337M1045Drug ManufacturersDrug Manufacturers - Specialty & Generic

Avadel Pharmaceuticals (AVDL) Competitor Comparison

We are evaluating the key criteria listed to compare Avadel Pharmaceuticals (AVDL) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 10 years - AVDL ranking 22 / 54

These are the competitors of Avadel Pharmaceuticals in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 10 years
1. ANI Pharmaceuticals ANIP
173.4
2. Alvotech ALVO
24.97
3. ProPhase Labs PRPH
14.25
4. Theratechnologies THTX
12.51
5. Evolus EOLS
11.93
6. Eagle Pharmaceuticals EGRX
9.12
7. Alimera Sciences ALIM
7.61
8. Vifor Pharma G2AB.F
7.23
9. Kamada KMDA
6.37
10. PetIQ PETQ
5.4
11. Kolinpharma KIP.MI
4.84
12. Linc LNC
4.73
13. Amphastar Pharmaceuticals AMPH
4.59
14. Phibro Animal Health PAHC
4.2
15. Emergent BioSolutions EBS
4.17
16. Cumberland Pharmaceuticals CPIX
3.87
17. Green Thumb Industries R9U2.F
3.84
18. Societal CDMO SCTL
3.72
19. Organogenesis Holdings ORGO
3.71
20. Ayr Wellness 3KJB.F
3.68
21. Curaleaf Holdings CURLF
3.36
22. Avadel Pharmaceuticals AVDL
3.28
23. Journey Medical DERM
3.04
24. Taro Pharmaceutical Industries TARO
2.87
25. Ironwood Pharmaceuticals IRWD
2.86
26. Elanco Animal Health ELAN
2.76
27. Amneal Pharmaceuticals AMRX
2.69
28. Procaps Group PROC
2.57
29. Cronos Group CRON
2.57
30. Pacira BioSciences PCRX
2.51
31. Embecta EMBC
2.39
32. Supernus Pharmaceuticals SUPN
2.32
33. Neoleukin Therapeutics NLTX
2.29
34. Tilray Brands TLRY
2.27
35. Catalent CTLT
2.12
36. Collegium Pharmaceutical COLL
2.08
37. Jupiter Wellness JUPW
1.84
38. Teva Pharmaceutical Industries TEVA
1.83
39. Alpha Teknova TKNO
1.81
40. Biofrontera BFRI
1.78
41. Flora Growth FLGC
1.77
42. Ascend Wellness Holdings AAWH
1.76
43. Perrigo PRGO
1.73
44. OptiNose OPTN
1.72
45. Zynerba Pharmaceuticals ZYNE
1.63
46. Clever Leaves Holdings CLVR
1.62
47. Universe Pharmaceuticals UPC
1.58
48. Solid Biosciences SLDB
1.57
49. Relmada Therapeutics RLMD
1.55
50. Zoetis ZTS
1.43
51. SCYNEXIS SCYX
1.37
52. Bausch Health Companies BHC
1.31
53. Regencell Bioscience Holdings RGC
1.27
54. Harrow Health HROW
0.51

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.

If you accept cookies, we use them to improve and personalize your experience. Manage Cookies